Nouhad Husseini
Director/Board Member at DECIBEL THERAPEUTICS, INC.
Profile
Currently, Nouhad Husseini is Director & Managing Director at Decibel Therapeutics, Inc. He is also Senior VP-Business Development at Regeneron Pharmaceuticals, Inc.
He received an undergraduate degree from Princeton University and an MBA from The Wharton School of the University of Pennsylvania.
Nouhad Husseini active positions
Companies | Position | Start |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2010-12-31 |
CHECKMATE PHARMACEUTICALS, INC. | Director/Board Member | 2022-05-30 |
DECIBEL THERAPEUTICS, INC. | Director/Board Member | 2023-09-21 |
Training of Nouhad Husseini
Princeton University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
DECIBEL THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |